clofibric acid has been researched along with Carbohydrate Inducible Hyperlipemia in 25 studies
Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ciprofibrate was convenient to take and was without subjective side effects." | 1.26 | Dose-response study of the effect of ciprofibrate on serum lipoprotein concentrations in hyperlipoproteinaemia. ( Olsson, AG; Orö, L, 1982) |
| "Treatment with clofibric acid over a long period of time may well give rise to additional reactions through influences exerted upon the insulin level." | 1.26 | [Effect of clofibric acid on fatty acid metabolism in HLP patients in the 2d half of life]. ( Reuter, W, 1982) |
| "Bezafibrate is a potent lipid-lowering agent of the new generation." | 1.26 | Clinical experience with bezafibrate. ( Hausmann, L; Kaffarnik, H; Mühlfellner, G; Mühlfellner, O; Schneider, J; Schubotz, R, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (96.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (4.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, J | 1 |
| Cao, H | 1 |
| Ban, MR | 1 |
| Kennedy, BA | 1 |
| Zhu, S | 1 |
| Anand, S | 1 |
| Yusuf, S | 1 |
| Pollex, RL | 1 |
| Hegele, RA | 1 |
| Kaffarnik, H | 2 |
| Schneider, J | 2 |
| Schubotz, R | 2 |
| Zöfel, P | 1 |
| Hausmann, L | 2 |
| Goebel, KM | 1 |
| Soler, J | 2 |
| Vinzia, C | 1 |
| Gómez, JM | 1 |
| Morató, J | 1 |
| Reuter, W | 2 |
| Neuman, MP | 1 |
| Kurlat, MI | 1 |
| Neuman, J | 1 |
| Olsson, AG | 1 |
| Orö, L | 1 |
| Altomonte, L | 2 |
| Mingrone, G | 2 |
| Negrini, A | 1 |
| De Cunto, F | 1 |
| Greco, AV | 2 |
| Bonora, V | 1 |
| Calalabuig, RJ | 1 |
| Caviola, E | 1 |
| Pueyo, JM | 1 |
| Micaló, T | 1 |
| Cano, RP | 1 |
| Ferreira, IJ | 1 |
| del Rio, A | 1 |
| González-Viejo, N | 1 |
| Vicens, B | 1 |
| Ferreira Montero, IJ | 1 |
| Gutiérrez Martín, M | 1 |
| del Río Ligorit, A | 1 |
| Casasnovas Lenguas, JA | 1 |
| Cornudella Lacasa, R | 1 |
| Schwandt, P | 2 |
| Weisweiler, P | 2 |
| Drosner, M | 1 |
| Janetschek, P | 1 |
| Schwartzkopff, W | 2 |
| Luley, C | 2 |
| Scheffler, W | 2 |
| Lehmann-Leo, W | 1 |
| Schilling, A | 2 |
| Wegscheider, K | 1 |
| Vessby, B | 1 |
| Lithell, H | 1 |
| Ledermann, H | 1 |
| Naruszewicz, M | 1 |
| Nowicka, G | 1 |
| Szostak, WB | 1 |
| Kłosiewicz-Latoszek, L | 1 |
| Mühlfellner, G | 1 |
| Mühlfellner, O | 1 |
| Lopez Rodriguez, J | 1 |
| Martorell, J | 1 |
| Ghirlanda, G | 1 |
| Manna, R | 1 |
| Rebuzzi, A | 1 |
| Pala, MA | 1 |
| Noseda, G | 1 |
| Fragiacomo, C | 1 |
| Weidmann, P | 1 |
| Bachmann, C | 1 |
| Hutt, V | 1 |
| Wechsler, JG | 1 |
| Klör, HU | 1 |
| Ditschuneit, H | 1 |
| Calder, D | 1 |
| Domingo, AJ | 1 |
| Gutiérrez, JA | 1 |
| Menéndez, JA | 1 |
| Micó, L | 1 |
| Muñoz, M | 1 |
| de Oya, M | 1 |
| Bolzano, K | 1 |
| Krempler, F | 1 |
| Schellenberg, B | 1 |
| Schlierf, G | 1 |
| Rodriguez, F | 1 |
| López, IM | 1 |
| Jover, E | 1 |
5 trials available for clofibric acid and Carbohydrate Inducible Hyperlipemia
| Article | Year |
|---|---|
[Double-blind study of the therapeutic activity of a new hypolipemic drug: etofibrate].
Topics: Adult; Aged; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Double-Blind Method; Female; Huma | 1981 |
Treatment of hyperlipoproteinemia, types II and IV, with pirifibrate: one hundred observations.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Clofibric Acid; Humans; Hyperlipoproteinemia Type | 1981 |
Double-blind study on the activity of plafibride in the treatment of type IV hyperlipoproteinemia.
Topics: Clinical Trials as Topic; Clofibrate; Clofibric Acid; Double-Blind Method; Female; Humans; Hyperlipo | 1981 |
[Controlled clinical trial of a new drug (plafibride) for the treatment of hyperlipoproteinemia type IV (author's transl)].
Topics: Adult; Aged; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Double-Blind Method; Female; Huma | 1982 |
[Efficacy of bezafibrate and fenofibrate on elevated blood lipids in HLP type IIa, IIb and IV].
Topics: Adult; Aged; Anticholesteremic Agents; Bezafibrate; Clofibrate; Clofibric Acid; Female; Fenofibrate; | 1982 |
20 other studies available for clofibric acid and Carbohydrate Inducible Hyperlipemia
| Article | Year |
|---|---|
Resequencing genomic DNA of patients with severe hypertriglyceridemia (MIM 144650).
Topics: Adult; Apolipoprotein A-V; Apolipoprotein C-II; Apolipoproteins A; Case-Control Studies; Clofibric A | 2007 |
Long-term treatment of hyperlipoproteinemia with etofibrate: clinical observations.
Topics: Adult; Aged; Cholesterol; Clofibrate; Clofibric Acid; Creatine Kinase; Female; gamma-Glutamyltransfe | 1980 |
[Plafibride treatment of hyperlipidemias type II and IV].
Topics: Adult; Cholesterol; Clofibrate; Clofibric Acid; Female; Humans; Hyperlipoproteinemia Type II; Hyperl | 1984 |
[Effect of combination therapy of clofibric acid and nicotinic acid derivatives on fatty acid metabolism in hyperlipoproteinemia].
Topics: Aged; Clofibrate; Clofibric Acid; Drug Therapy, Combination; Fatty Acids; Female; Humans; Hyperlipop | 1982 |
Elevation of high density lipoprotein cholesterol (cHDL) and reduction of the total cholesterol/cHDL index in the treatment of hyperlipoproteinaemias IIb and IV with bezafibrate.
Topics: Adult; Aged; Bezafibrate; Cholesterol; Cholesterol, HDL; Clofibrate; Clofibric Acid; Female; Humans; | 1983 |
Dose-response study of the effect of ciprofibrate on serum lipoprotein concentrations in hyperlipoproteinaemia.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Blood Sedimentation; Body Weight; Cholesterol; Ch | 1982 |
Effects of bezafibrate on the composition of very low density lipoproteins in type IV hyperlipoproteinemia.
Topics: Apolipoprotein C-I; Apolipoprotein C-II; Apolipoproteins; Apolipoproteins C; Apolipoproteins E; Beza | 1982 |
Elevated lipoprotein lipase activity in skeletal muscle tissue during treatment of hypertriglyceridaemic patients with bezafibrate.
Topics: Adipose Tissue; Adult; Bezafibrate; Clofibrate; Clofibric Acid; Female; Humans; Hyperlipoproteinemia | 1982 |
[Effect of clofibric acid on fatty acid metabolism in HLP patients in the 2d half of life].
Topics: Adult; Aged; Cholesterol Esters; Clofibrate; Clofibric Acid; Fatty Acids; Female; Humans; Hyperlipop | 1982 |
[Effect of bezafibrate on lipid and apoprotein levels in patients with idiopathic hypertriglyceridemia].
Topics: Adult; Aged; Apolipoproteins; Bezafibrate; Cholesterol; Clofibrate; Clofibric Acid; Female; Humans; | 1982 |
Effect of bezafibrate on the high-density lipoprotein subfractions HDL2 and HDL3 in primary hyperlipoproteinemia type IV.
Topics: Adult; Apolipoproteins; Bezafibrate; Cholesterol; Clofibrate; Clofibric Acid; Humans; Hyperlipoprote | 1980 |
Clinical experience with bezafibrate.
Topics: Bezafibrate; Blood Glucose; Body Weight; Cholesterol; Clofibrate; Clofibric Acid; Coronary Disease; | 1980 |
Pirifibrate in the treatment of hyperlipoproteinemia: types IIa, IIb, and IV.
Topics: Adolescent; Adult; Aged; Cholesterol; Clofibric Acid; Humans; Hyperlipoproteinemia Type II; Hyperlip | 1980 |
[Bile lipid composition in subjects with blood lipid disorders (types II and IV). Effect of a new hypolipemic drug (Etofibrate)].
Topics: Adult; Aged; Bile; Clofibrate; Clofibric Acid; Female; Humans; Hyperlipoproteinemia Type II; Hyperli | 1980 |
[The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types].
Topics: Bezafibrate; Cholesterol; Clofibrate; Clofibric Acid; Humans; Hyperlipoproteinemia Type II; Hyperlip | 1980 |
Changes in lipids and lipoproteins in patients with hyperlipidemia type IIb, IV and V treated with different lipid lowering drugs.
Topics: Anticholesteremic Agents; Bezafibrate; Cholesterol; Clofibrate; Clofibric Acid; Humans; Hyperlipopro | 1980 |
The effect of etofibrate retard, bezafibrate and procetofen.
Topics: Aged; Bezafibrate; Cholesterol; Clofibrate; Clofibric Acid; Female; Fenofibrate; Humans; Hyperlipopr | 1980 |
Pirifibrate in the treatment of hyperlipoproteinemias: a multicenter study.
Topics: Adult; Aged; Clofibric Acid; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type | 1980 |
[A comparison of bezafibrate and clofibrate in type II B and type IV hyperlipoproteinemia].
Topics: Adult; Aged; Bezafibrate; Clofibrate; Clofibric Acid; Dose-Response Relationship, Drug; Female; Huma | 1979 |
Plafibride treatment and serum lipids in hyperlipoproteinemias.
Topics: Adolescent; Adult; Blood Glucose; Cholesterol; Clofibrate; Clofibric Acid; Diet; Female; Humans; Hyp | 1987 |